ClinicalTrials.gg
RecruitingNCT07854288Updated Oct 2, 2026

Maitland Mobilization With and Without Stroking Release Technique of Rotator Cuff Muscle in Frozen Shoulder

An interventional study of Maitland mobilization combined with Stroking release technique and Maitland Mobilization, along with baseline treatment in Adhesive Capsulitis, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled May 2026, registered Sep 2026).
  • Started May 2026; still recruiting 6 months later.
Updated Oct 2, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Bursitis by Riphah International University — 17 open to participants now, 17 under way, none of them phase 3. Bursitis · Riphah International University.

Planned enrollment
11th of 52
44 · median 38
Started
2026
with 5 others
No phase
52 of 52
17 open now
Primary completion
2026-11
later than 13 of 16 live
Registered
51st of 52
by date

Among the 52 studies in Bursitis by Riphah International University, this one is the 11th largest by planned enrollment, is one of 6 that started in 2026, is one of 52 with no phase, reaches primary completion later than 13 of the 16 other live ones, and was the 51st registered.

Bursitis

384 studies on the registry are indexed under Bursitis; 111 are open to participants now.

Browse Bursitis studies →

Open to participants now

17 of the 52 studies in Bursitis by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

11 more — sign in →

By country, each count listing its studies:

All 17 open studies →

Where they have run

Who these studies take

Of the 65 Bursitis studies recruiting now, 16 (25%) set no upper age limit and 42 (65%) stop at 75 or younger; none take children under 18; 8 take healthy volunteers.

This study: 40 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Bursitis by Riphah International University, or all of them as a file.
02

Study summary

Frozen shoulder has been described as a painful condition associated with stiffness and difficulty in sleeping on the affected side. People with this condition have difficulty in dressing, overhead movements and sleep disturbance. It occurs in 2 - 5% of general adult population, 10 - 15% of the people with diabetes. It mainly affects the individuals of 35 - 65 years of age with female predominance. Frozen shoulder is characterized by fibroproliferative tissue fibrosis whereby fibroblasts, producing predominantly type I and type III collagen, transform into myofibroblasts, which is accompanied by inflammation, resulting in shoulder capsular fibrotic contractures and the associated clinical stiffness.

There are two frozen shoulder syndromes, namely primary syndrome and secondary syndrome. In primary or idiopathic syndrome, frozen shoulder that occurs spontaneously or directly without knowing the causative factors. Primary syndrome occurs due to a chronic inflammatory response with fibroblast proliferation which can actually be a response from an abnormal immune system. Secondary syndromes occur due to several triggers such as trauma that can cause shoulder injuries or surgery associated with the onset of other conditions such as diabetes mellitus, autoimmune diseases and cardiovascular disorders.

The clinical presentation of frozen shoulder typically progresses through three stages: the freezing stage, where the shoulder becomes painful and progressively stiff over two to nine months; the frozen stage, characterized by significant stiffness and reduced pain over four to twelve months; and the thawing stage, where gradual improvement in shoulder mobility occurs over five to twenty-four months. The condition can be severely debilitating, impacting daily activities and overall quality of life.

Adhesive capsulitis treatment primarily consists of pain relief and physical therapy techniques. Anti-inflammatory medication is helpful in pain relief, so that mobility interventions can be initiated. Therapeutic modalities include Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Therapy (IFT), Ultrasound, Short Wave Diathermy (SWD) etc, and the physical therapy exercises such as stretching, Codman exercise can be used. Exercises which may be active, passive or active assisted, play a crucial role in the early rehabilitation of these patients.

Read the detailed description

Myofascial treatment is an emerging treatment in different musculoskeletal conditions although its clinical benefits is still not clearly understood. Myofascial release therapy (MRT) aims at restoring the normal length of a tight structure with the target goal of decreasing pain and improving function. Since patients with frozen shoulder presents with tightness of rotator cuff muscles, Stroking release technique can be effective in treatment of frozen shoulder.

Rotator cuff is the dynamic stabilizer of the glenohumeral joint (GHJ). It depresses and compresses the humeral head on the glenoid cavity and prevents superior translation of the humerus. Therefore, Rotator Cuff dysfunction, weakness, or rupture may reduce GHJ stability. Rotator cuff rupture also causes shoulder pain, muscle weakness, decrease of shoulder range of motion (ROM), and function. Additionally, fear of movement develops due to shoulder pain and affects ROM and function.

The scapulothoracic joint is not a true joint but functions as an integral part of the shoulder complex. Scapulothoracic movements that include rotation, elevation, depression, protraction, retraction, and circumduction are important for the normal functioning of the shoulder. Scapular mobilization is a widely used manual therapy technique for the management of musculoskeletal disorder of the shoulder, it involves the manual application of a sustained mobilization (in 4 directions) to the scapulothoracic joint.

Codman pendulum is a technique, in the form of arm swing movements with a bent body position and the self-mobilization technique. Scapular mobilization is a treatment technique used for the management of shoulder musculoskeletal disorders. Scapular mobilization aims to mobilize joints or distractions, thus providing scapulothoracic distance and muscles will be extended. By controlling movement from the position of the scapula can help the glenoid in its normal position.

Maitland mobilization (MM) is a manual technique commonly used in the physiotherapy management of FS. It applies passive oscillations, classified from Grade I-IV with respect to amplitude and intensity, to the shoulder in order to treat pain and stiffness. Grades I and II of Maitland mobilization techniques are primarily used for treating joints limited by pain. Whereas Grades III and IV are primarily used as stretching maneuver. There are few previous studies which prove the effect of MM on pain and ROM among FS patients .

Frozen shoulder is a condition with pain and limited range of motion. It is often managed with maitland mobilization. Rotator cuff muscle can contribute to persistent pain and limited function. Very few studies have examined the role of Stroking release technique of rotator cuff muscle in frozen shoulder treatment. This study aims to evaluate the added benefit of Stroking Release technique of Rotator cuff muscle in improving pain, ROM, and disability. The findings could guide clinicians toward more comprehensive and effective treatment protocols. In the future, this approach may lead to faster recovery and improved quality of life for patients.

03

Conditions studied

  • Adhesive Capsulitis

Browse trials for

Keywords

  • Pian
  • Disability
  • Adhesive Capsulitis
  • Mobilization
04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 40 to 60 years
  • Stage 2 and 3 Frozen shoulder
  • Positive capsular pattern
  • Positive Apley's scratch test
  • Unilateral Frozen Shoulder

Exclusion criteria

Exclusion Criteria:

  • Rotator cuff disease
  • Post CABG
  • Post stroke frozen shoulder
  • Fracture of shoulder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Group A

    Maitland mobilization combined with Stroking release technique of rotator cuff muscle

    Other: Maitland mobilization combined with Stroking release technique

  • Active comparator
    Group B

    Maitland mobilization

    Other: Maitland Mobilization, along with baseline treatment

Interventions

  • OtherMaitland mobilization combined with Stroking release technique

    Maitland mobilization combined with Stroking release technique of Rotator cuff muscles, along with baseline treatment * Maitland mobilization: * Perform using Grades III and IV glides (anterior, posterior, inferior) targeting the glenohumeral joint. * Aimed at reducing stiffness and improving range of motion. * 3 sets for 30 sec. * Rotator cuff muscle release: (Stroking release technique) * Manual muscle release of supraspinatus, Infraspinatus, Subscapularis and Teres minor for 15 minutes. (2-3 reps per muscle and 1 set per muscle per session) * It will help to reduce muscle tightness and improve mobility 1. Supraspinatus release: The patient will be in sitting or side-lying. Palpate just above the spine of the scapula. Use thumb pressure along muscle fibres. Move from distal end to proximal. 2. Infraspinatus release: The patient will be in a sitting position. Locate the muscle below the spine of the scapula. Apply thumb pressure along muscle fibres or cross friction.

  • OtherMaitland Mobilization, along with baseline treatment

    Maitland Mobilization, along with baseline treatment No additional soft tissue work was performed on the rotator cuff muscles. Baseline treatment will be: Hot pack and TENS for 10 minutes Scapular mobilization: Scapular mobilization is performed in a side-lying with the patient relaxed. The therapist passively mobilizes the scapula in different directions to improve scapulothoracic rhythm and reduce stiffness. Techniques used will be: * Scapular elevation, depression * Scapular protraction, retraction 3 sets of 6-8 mobilizations in each direction. 1 session per day and 3 sessions per week (26). Codman exercises: Codman exercises help promote passive motion of the shoulder joint without activating the shoulder musculature, reducing pain and improving mobility. Patient leans forward, hanging the affected arm freely. Small pendulum-like motions are performed in: * Circular motion * Forward back swing * Side-to-side swing 4 sets of 6-8 reps in each direction

06

What researchers measure

Primary outcomes

  1. Numeric pain rating scale (NPRS)

    The Numeric Pain Rating Scale (NPRS) is a widely used tool designed to assess pain intensity in both clinical and research settings. It consists of an 11-point scale ranging from 0 to 10, where 0 represents "no pain" and 10 indicates the "worst imaginable pain." NPRS is a quick and straightforward method, commonly used to track changes in pain over time, particularly in musculoskeletal and postoperative populations

    Time frame: Baseline; Week 3; Week 6

  2. Universal Goniometer

    The goniometer is a widely used instrument in clinical and rehabilitation settings to measure joint angles and assess the range of motion (ROM). It helps clinicians monitor progress and identify movement limitations in patients with musculoskeletal conditions.

    Time frame: Baseline; Week 3; Week 6

  3. Shoulder pain and disability index

    It is a self-administered questionnaire designed to evaluate pain and functional impairment related to shoulder disorders. It consists of 13 items, divided into pain and disability subscales, and is often used in both clinical practice and research.

    Time frame: Baseline; Week 3; Week 6

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Eybye MN, Madsen SD, Schultz ANO, Nim CG. Database coverage and their use in systematic reviews regarding spinal manipulative therapy: an exploratory study. Chiropr Man Therap. 2022 Dec 19;30(1):57. doi: 10.1186/s12998-022-00468-8. PubMed 36536437 ↗
  • Deodato M, Martini M, Buoite Stella A, Citroni G, Ajcevic M, Accardo A, Murena L. Inertial Sensors and Pressure Pain Threshold to Evaluate People with Primary Adhesive Capsulitis: Comparison with Healthy Controls and Effects of a Physiotherapy Protocol. J Funct Morphol Kinesiol. 2023 Oct 6;8(4):142. doi: 10.3390/jfmk8040142. PubMed 37873901 ↗
  • Satpute K, Reid S, Mitchell T, Mackay G, Hall T. Efficacy of mobilization with movement (MWM) for shoulder conditions: a systematic review and meta-analysis. J Man Manip Ther. 2022 Feb;30(1):13-32. doi: 10.1080/10669817.2021.1955181. Epub 2021 Aug 1. PubMed 34334099 ↗
  • Phansopkar P, Qureshi MI. Impact of Spencer Technique on Pain, Range of Motion, and Functional Disability in Patients With Frozen Shoulder: A Pilot Study. Cureus. 2024 Jan 30;16(1):e53263. doi: 10.7759/cureus.53263. eCollection 2024 Jan. PubMed 38435910 ↗
  • Phansopkar P, Qureshi MI. An Integrated Physical Therapy Using Spencer's Technique in the Rehabilitation of a Patient With a Frozen Shoulder: A Case Report. Cureus. 2023 Jun 30;15(6):e41233. doi: 10.7759/cureus.41233. eCollection 2023 Jun. PubMed 37529524 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Nov 2026, 6 months after the start.

Of 219 non-industry interventional studies with no phase under Bursitis, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 17. This study's planned 6 months is below that.

Counting every sponsor, half of 219 studies reached it within 10 months; a quarter within 5 and three quarters within 17.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2026
First posted
Oct 2, 2026
StartActual
May 1, 2026
Primary completionEst.
Nov 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07854288
Responsible party
Sponsor
First posted
Oct 2, 2026
Start date
May 1, 2026
Primary completion
Nov 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Oct 2, 2026

Study contacts

Syed Shakil ur Rehman, PhD
Contact
shakil.urrehman@riphah.edu.pk
+92 320 786661
Muhammad Umar Hasnain, MS
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion